Targeting KDM2A Enhances T-cell Infiltration in NSD1-Deficient Head and Neck Squamous Cell Carcinoma
Authors:
- Chen ChenCCChen Chen
- June Ho. ShinJSJune Ho. Shin
- Zhuoqing FangZFZhuoqing Fang
- Kevin BrennanKBKevin Brennan
- Nina B. HorowitzNHNina B. Horowitz
- Kathleen L. PfaffKPKathleen L. Pfaff
- Emma L. WelshEWEmma L. Welsh
- Scott J. RodigSRScott J. Rodig
- Olivier GevaertOGOlivier Gevaert
- Or GozaniOGOr Gozani
- Ravindra UppaluriRURavindra Uppaluri
- John B. SunwooJSJohn B. Sunwoo
- 13 June 2023
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 83 (16) , 2645-2655
Abstract
In head and neck squamous cell carcinoma (HNSCC), a significant proportion of tumors have inactivating mutations in the histone methyltransferase NSD1. In these tumors, NSD1 inactivation is a driver of T-cell exclusion from the tumor microenvironment (TME). A better understanding of the NSD1-mediated mechanism regulating infiltration of T cells into the TME could help identify approaches to overcome immunosuppression. Here, we demonstrated that NSD1 inactivation results in lower levels of H3K36 dimethylation and higher levels of H3K27 trimethylation, the latter being a known repressive histone mark enriched on the promoters of key T-cell chemokines CXCL9 and CXCL10. HNSCC with NSD1 mutations had lower levels of these chemokines and lacked responses to PD-1 immune checkpoint blockade. Inhibition of KDM2A, the primary lysine demethylase that is selective for H3K36, reversed the altered histone marks induced by NSD1 loss and restored T-cell infiltration into the TME. Importantly, KDM2A suppression decreased growth of NSD1-deficient tumors in immunocompetent, but not in immunodeficient, mice. Together, these data indicate that KDM2A is an immunotherapeutic target for overcoming immune exclusion in HNSCC. Significance: The altered epigenetic landscape of NSD1-deficient tumors confers sensitivity to inhibition of the histone-modifying enzyme KDM2A as an immunotherapeutic strategy to stimulate T-cell infiltration and suppress tumor growth.Keywords
All Related Versions
Funding Information
- National Institute of Dental and Craniofacial Research (R35DE030054)
This publication has 44 references indexed in Scilit:
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptorsNature Medicine, 2015
- Molecular Pathways: Deregulation of Histone H3 Lysine 27 Methylation in Cancer—Different Paths, Same DestinationClinical Cancer Research, 2014
- Ezh2 Regulates Transcriptional and Posttranslational Expression of T-bet and Promotes Th1 Cell Responses Mediating Aplastic Anemia in MiceThe Journal of Immunology, 2014
- The Polycomb Protein Ezh2 Regulates Differentiation and Plasticity of CD4+ T Helper Type 1 and Type 2 CellsImmunity, 2013
- Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemiaNature Genetics, 2013
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortalScience Signaling, 2013
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- Histone demethylation by a family of JmjC domain-containing proteinsNature, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001